SC Filed 2021-02-05 Event — SEC 0001104659-21-012441 →

Syntone Ventures LLC → Outlook Therapeutics, Inc. OTLK

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

5 transactions

3 buys · 0 sales · 0 awards/exercises

Issuer Cluster

14 13D/G filings on this issuer

13 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.24

11,240,969 shares short · -19.8% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-05-28	Sukhtian Ghiath M.	director, 10%+ owner	Buy	8,539,709	$0.59	$5.00M
2026-05-28	Sukhtian Ghiath M.	director, 10%+ owner	H	3,458,571	$2.26	$7.82M
2026-05-28	Sukhtian Ghiath M.	director, 10%+ owner	Buy	3,458,571	$0.59	$2.02M
2026-05-28	Sukhtian Ghiath M.	director, 10%+ owner	H	8,571,428	$1.40	$12.00M
2026-05-28	Sukhtian Ghiath M.	director, 10%+ owner	Buy	8,571,428	$0.59	$5.02M

Other 13D/G Filings on Outlook Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-01	SCHEDULE 13D/A	GMS Ventures & Investments	—	37,580,638	view →
2025-01-22	SCHEDULE	GMS Ventures & Investments	38.60%	12,725,216	view →
2022-07-08	SC	Tenshi Healthcare Pte. Ltd.	—	—	view →
2022-02-01	SC	BioLexis Pte Ltd.	—	—	view →
2021-02-02	SC	BioLexis Pte Ltd.	—	—	view →
2020-03-24	SC	BioLexis Pte Ltd.	—	—	view →
2020-02-27	SC	BioLexis Pte Ltd.	—	—	view →
2020-01-31	SC	BioLexis Pte Ltd.	—	—	view →
2019-12-30	SC	BioLexis Pte Ltd.	—	—	view →
2019-04-17	SC	BioLexis Pte Ltd.	—	—	view →
2019-02-05	SC	BioLexis Pte Ltd.	—	—	view →
2019-01-03	SC	BioLexis Pte Ltd.	—	—	view →
2018-01-05	SC	SABBY MANAGEMENT, LLC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →